Bush Keeps Klausner As NCI Director; Senate Confirms Thompson For HHS.
Golde To Step Down As Physician-in-Chief At Memorial Sloan-Kettering Next Year.
Golde To Step Down At MSK; Porter Joins Hogan & Hartson.
FASEB Calls For 15% Increase For NIH Next Fiscal Year.
Holden Center At U. Of Iowa Designated Comprehensive.
Obit: George Santos, Hopkins Cancer Treatment Pioneer.
Course On Human Research Protections Goes Online @ Cancer.Gov.
FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.
NCCN Updates Treatment Guidelines To Include CEF For Early Breast Cancer.
US Oncology To Participate In Firm’s Ovarian Cancer Trial.
Atrix, Sanofi In Marketing Deal For Leuprogel Products.
Trending Stories
- Senators slam Bhattacharya for deflecting responsibility for NIH cuts, upheaval
Susan Collins: Trump’s 40% cut is “so disturbing” - The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
Directors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it” - In the Headlines: Missing record of NCAB meetings restored to NIH website
- Insights from ASCO 2025: Real-world evidence drives clinical decision-making
- In first NCAB meeting since Trump’s inauguration, Lowy reflects on funding choices in lean times
“In the NCI director’s office, we have a photograph of a stone bridge, and it asks the question, which stone holds up the bridge? And the answer is all of them.”